feed,title,long_url,short_url
SeekingAlpha,Lannett slides 28% after pricing pressure hits Q2 sales and 2022 outlook,https://seekingalpha.com/news/3796107,
SeekingAlpha,Twist Biosciences shares in the red despite raising FY 2022 expected revenue,https://seekingalpha.com/news/3796108,
